The drugmaker is eager to recast itself as a high-multiple growth stock. The expected growth will be fired up by 25 product launches, which Pfizer is explaining in two days of online talks.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences. An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
Daily injections of vosoritide sped up growth rates for children with the most common form of dwarfism.